Friday, November 13, 2026

Harm reduction, not border cops, credited for historic drop in US overdose deaths

Experts say grassroots public health efforts—not federal drug crackdowns—are driving the largest decline in overdose deaths ever recorded, despite ongoing political attacks on harm reduction.

It’s getting worse: The IRS now audits poor Americans at about the same rate...

As the agency’s ability to audit the rich crumbles, its scrutiny of the poor has held steady in recent years. Meanwhile, a new study shows that audits of poor taxpayers make them far less likely to claim credits they might be entitled to.
video

The case against Joe Biden: Former VP’s long career shows a recurring theme of...

Biden’s approach to politics is based on “appeasing the right” and “taking the platform of his Republican opponent and trying to make it his own.”

The Iraq War was a huge ethical leap backwards

From the Big Lie to torture and sectarian violence, the U.S. and the Middle East are still paying the price for our moral perversions in Iraq.

Bernie Sanders ends 2020 campaign with vow to continue struggle for ‘what we are...

“Let us go forward together. The struggle continues.”

It’s only a mid-term—however daunting the threat

The remedy to fascist excess/ Is activist, real-world progress.

Trump boat bombings draw murder accusations from Amnesty and lawmakers

A widening human rights crisis emerges as new disclosures reveal orders to kill shipwrecked survivors.

Biden must take on Big Pharma over cancer drug that costs $189,000 per year

The United States government should be using its investments in medical research and innovation to benefit all Americans, not just the shareholders at a few corporations.

Omnicide Joe?

Whether heralded or reviled, Biden’s supposed restraint during the Ukraine war has steadily faded, with more and more dangerous escalation in its place.

Sanders proposes 50% public stake in leading AI companies

New legislation would create a sovereign wealth fund funded through equity transfers from major artificial intelligence firms, aiming to distribute AI-generated wealth beyond Silicon Valley investors.